News Headlines Article

Hopes for Alzheimer’s Drug Are Dashed
New York Times

It seemed somewhat unlikely, but in recent years an old Russian hay fever pill had become one of the world’s best hopes for treating the growing epidemic of Alzheimer’s disease. But those hopes were dashed on Wednesday when the drug failed in its first late-stage clinical trial, dealing a blow not only to patients with Alzheimer’s and their families but to the companies developing the treatment — a start-up in San Francisco called Medivation and the world’s largest drug company, Pfizer.